CorMedix Inc (NASDAQ:CRMD)
| 5.12 BATS BZX Real-Time Price As of 10:46am ET |  -0.07 / -1.35%Today’s Change | 2.65 Today|||52-Week Range 8.03 | +21.33% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $232.8M |
Company Description
CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.
Contact Information
CorMedix, Inc. 300 Connell Drive Berkeley Heights New Jersey 07922 |
Employees
Shareholders
| Mutual fund holders | 5.92% |
| Individual stakeholders | 3.36% |
| Other institutional | 18.59% |
Top Executives
| Joseph Todisco | Chief Executive Officer & Director |
| Mathew T. David | Chief Financial Officer & Executive Vice President |
| Antony E. Pfaffle | Secretary & Chief Scientific Officer |
| Elizabeth Masson-Hurlburt | Executive VP-Clinical & Medical Affairs |
| Tushar Mukherjee | Senior Vice President-Technical Operations |
